Plasma mid-regional pro-atrial natriuretic peptide and N-terminal pro-brain natriuretic peptide improve discrimination of lone atrial fibrillation

被引：5

作者：

Chang, Ian C. Y. ^{[1
]}

Chen, Lin Y. ^{[1
]}

Chong, Jenny P. C. ^{[2
]}

Austin, Erin ^{[3
]}

Quay, Chwee N. ^{[2
]}

Gong, Lingli ^{[2
]}

Richards, A. Mark ^{[2
,4
,5
]}

Ling, Lieng H. ^{[2
,5
]}

机构：

[1] Univ Minnesota, Dept Med, Cardiovasc Div, Minneapolis, MN 55455 USA

[2] Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Med, Singapore 117548, Singapore

[3] Univ Minnesota, Sch Publ Hlth, Div Biostat, Minneapolis, MN 55455 USA

[4] Univ Otago, Christchurch Heart Inst, Dunedin, New Zealand

[5] Natl Univ Heart Ctr, Dept Cardiac, Singapore, Singapore

来源：

INTERNATIONAL JOURNAL OF CARDIOLOGY | 2015年 / 188卷

基金：

英国医学研究理事会;

关键词：

Atrial fibrillation; Biomarkers; Case-control study; Mid-regional pro-atrial natriuretic peptide; N-terminal pro-brain natriuretic peptide;

D O I：

10.1016/j.ijcard.2015.03.415

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

[No abstract available]

引用

页码：10 / 12

页数：3

共 50 条

[31] Assessment of N-terminal pro-brain natriuretic peptide level in the screening for atrial fibrillation in the primary health care
Ghazal, F.
Theobald, H.
Rosenqvist, M.
Al-Khalili, F.
EUROPEAN HEART JOURNAL, 2018, 39 : 417 - 417
[32] B-type natriuretic peptide over N-terminal pro-brain natriuretic peptide to predict incident atrial fibrillation after cryptogenic stroke
Pala, E.
Pagola, J.
Juega, J.
Francisco-Pascual, J.
Bustamante, A.
Penalba, A.
Comas, I.
Rodriguez, M.
De Lera Alfonso, M.
Arenillas, J. F.
de Torres, R.
Perez-Sanchez, S.
Cabezas, J. A.
Moniche, F.
Gonzalez-Alujas, T.
Molina, C. A.
Montaner, J.
EUROPEAN JOURNAL OF NEUROLOGY, 2021, 28 (02) : 540 - 547
[33] Mid-regional pro-atrial natriuretic peptide and the assessment of volaemic status and differential diagnosis of profound hyponatraemia
Nigro, N.
Winzeler, B.
Suter-Widmer, I.
Schuetz, P.
Arici, B.
Bally, M.
Blum, C. A.
Nickel, C. H.
Bingisser, R.
Bock, A.
Savoca, K. Rentsch
Huber, A.
Mueller, B.
Christ-Crain, M.
JOURNAL OF INTERNAL MEDICINE, 2015, 278 (01) : 29 - 37
[34] N-terminal pro-atrial natriuretic peptide and exercise prescription in patients with myocardial infarction
Ikeda, Nahoko
Yasu, Takanori
Nishikimi, Toshio
Nakamura, Tomohiro
Kubo, Norifumi
Kawakami, Masanobu
Momomura, Shin-ichi
Saito, Muneyasu
REGULATORY PEPTIDES, 2007, 141 (1-3) : 154 - 158
[35] Mid-regional pro-atrial natriuretic peptide and copeptin as indicators of disease severity and therapy response in CTEPH
Kriechbaum, Steffen D.
Scherwitz, Lillith
Wiedenroth, Christoph B.
Rudolph, Felix
Wolter, Jan-Sebastian
Haas, Moritz
Fischer-Rasokat, Ulrich
Rolf, Andreas
Hamm, Christian W.
Mayer, Eckhard
Guth, Stefan
Keller, Till
Konstantinides, Stavros, V
Lankeit, Mareike
Liebetrau, Christoph
ERJ OPEN RESEARCH, 2020, 6 (04) : 1 - 11
[36] Mid-regional pro-atrial natriuretic peptide for the early detection of non-acute heart failure
Gohar, Aisha
Rutten, Frans H.
den Ruijter, Hester
Kelder, Johannes C.
von Haehling, Stephan
Anker, Stefan D.
Moeckel, Martin
Hoes, Arno W.
EUROPEAN JOURNAL OF HEART FAILURE, 2019, 21 (10) : 1219 - 1227
[37] N-TERMINAL PRO-BRAIN NATRIURETIC PEPTIDE AND METABOLIC SYNDROME
Lin, J. -W.
Chiu, F. -C.
Hwang, J. -J.
ATHEROSCLEROSIS SUPPLEMENTS, 2010, 11 (02) : 41 - 41
[38] N-Terminal Pro-Brain Natriuretic Peptide Trial Design
Hersh, Andrew
Aberegg, Scott K.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2017, 196 (04) : 530 - 530
[39] N-TERMINAL PRO-BRAIN NATRIURETIC PEPTIDE LEVEL IN SSc
Pinto, S.
Videira, T.
Ferreira, P.
RHEUMATOLOGY, 2012, 51 : 116 - 117
[40] Clinical significance of N-terminal pro-brain natriuretic peptide
张向阳
朱继红
中华医学杂志(英文版), 2004, (11) : 116 - 122

← 1 2 3 4 5 →